ThePharmyard Click here to see all PharmaVentures titles in ThePharmYard
AccesPay-as-you-go medical and pharmaceutical industry information About Us | Contact Us | Terms
Store search
Careers Advice
Discovery R & D
Drugs+Devices
General Industry
Health+Medicine
Practical Skills
Sales+Marketing
Special Deals
The Publishers
Tell a friend
Managed by NetworkPharma
Upcoming Events for Pharmaceutical Industry Executives

8th Cold Chain Management & Temperature Control Summit
23-25 February 2010, Toronto, Ontario, organized by IQPC
[More details]

TIPPA’s 2010 Midwest Meeting: Tackling the Authorship Debate in Publication Planning
25-26 February 2010, Chicago, IL, organized by TIPPA
[More details]

Early Disease Detection and Prevention (EDDP)
25-28 February 2010, Munich, Germany, organized by Paragon conventions
[More details]

Process & Product Validation
1-2 March 2010, La Costa Resort and Spa, Carlsbad, CA, organized by IBC USA
[More details]

MORE EVENTS

Can European VCs and Universities Make Money from New Biotech Spin-Offs?

Reprinted from PharmaDeals Review this Feature Article draws upon expert analysis and business intelligence data from the team at PharmaVentures to provide an up-to-date assessment of new developments.

Product Details - See below for further product information
 Note the document you buy is licensed for your own use only.

File type and size: PDF 0.229 MB
Publication size: 3 pages
Publication date: December 2005
Published by: PharmaVentures
ThePharmYard product code: pventures124

Our Price: £35.00
You are buying an e-document. This is a digital product and therefore UK VAT @ 17.50 % will be added at Checkout if your billing address is in the EU.

Related Products:

Further Product Information

Written b Dr Jonathan Savidge, Business Development Manager, UCL Biomedica plc

INTRODUCTION

The ability of early-stage biotechs, in particular spin-offs from universities, to obtain Series A/first round financing depends upon the venture capitalists (VCs) that make this type of investment being able to secure successful exits. In addition, any ultimate return to the university from a spin-off depends upon the value of the company rising at each VC round. ‘Down rounds’, where the share price falls, lead to often catastrophic dilution of the shareholding of a university, which is rarely in a position to invest cash to maintain its position. The result is that even if the company is ultimately successful, and the investors secure a profitable exit, the university may not necessarily share in that financial success.




ABOUT PHARMADEALS REVIEW

PharmaDeals Review analyses specific deals and examines trends and developments within deal making in different technology and therapy areas. It also assesses data from PharmaDeals Agreements and details product licensing openings from PharmaDeals Opportunities. Individual deals and selected companies' collaborative histories are reviewed, providing useful insight into their deal making strategies. PharmaDeals Review offers a means of quickly reviewing competitive alliances, and assessing their impact on your business.
Register now for Health 2.0, Paris, 6-7 April 2010

Health 2.0, Paris, 6-7 April 2010

Programme and registration details here
What we do

ThePharmYard sells information relevant to the medical and pharmaceutical industries, on behalf of independent publishers, in the form of e-documents. Buy online now and access the information immediately.

If you have any problems or questions or comments of any sort, then do please contact us directly.

Change Currency Here
worldpay
All transactions conducted independently by WorldPay
basket
basket		 checkout
checkout		 Terms
terms
Browse all publications in ThePharmYard from PharmaVentures.
More about PharmaVentures

PharmaVentures is a leading results driven organisation assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making. Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence, we work with our clients to drive greater value from their deals. With over 12 years experience of working with clients on more than 450 different projects, we provide the global expertise to ensure you generate the highest possible return on investment from all your deal making activities.

For more information about PharmaVentures please visit their own web site.

Selected Special Offers
1. Venlafaxine in Depression (in Primary Care)
2. Tiotropium in COPD (in Primary Care)
3. Pravastatin in Lipid Disorders (in Primary Care)
4. Escitalopram in Depression (in Primary Care)
5. Nicorandil in Angina (in Primary Care)

Our Best Sellers
1. European CME accreditation
2. Pneumococcal Infections - Disease overview
3. Creating and using customer insight: 12 Rules of best practice
4. Brand momentum: The measure of great pharmaceutical brands
5. An overview of CME/CPD credit systems around the world
6. eDetailing Special Supplement
7. Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?
8. Distribution channels
9. Stepping up to Medical Sales Success - 2nd Edition
10. Branding pharmaceuticals

Latest Additions
1. Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb
2. The World Market for Addiction Disorders, 2009 - 2016: Future Therapies for Substance Dependence and Impulse Control
3. Drug Delivery Partnering Agreements in Pharma and Biotech
4. Distribution and Patient Support for Speciality Medicines in Europe
5. Report of The International Publication Planning Association's 7th Annual Meeting

Need help?

If you can't find what you are looking for, or have any problems or questions or comments at all, then please contact us directly.

If you are an Author or Publisher and have one or more publications you would like to make available to our specialist medical and pharmaceutical industry audience, then please contact us directly.

If you run your own web site and want to earn money from our affiliate scheme then please contact us directly.
Affiliates | About Us | Contact Us | Terms

ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2010

Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePublicationPlan.com]

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo